Delivery Order SPE2DB22D3301-SPE2DB24FX8EF

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTP26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,911.04 delivery order contract is for the supply of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB22FP78Y, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,523.28 firm fixed-price delivery order is for the procurement of HUMIRA PEN 40 MG/0.8 MLS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 9, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA2D7, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $1,510.60, is a delivery order for the pharmaceutical product HUMIRA PEN 40 MG/0.8 MLS. It is a firm-fixed-price contract with a completion date of January 24, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
The federal contract award SPE2DB22D2007|SPE2DB25FH7LZ was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,446.43 Firm Fixed Price Delivery Order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the...
This federal contract award, with ID SPE2DB22D3009|SPE2DB24FAP15, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $43,454.42 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award, with the ID SPE2DB25D3018|SPE2DB25FUXAJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,265.90 and a final completion date of March 18, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major...
This federal contract award SPE2DB20D3103|SPE2DB25FL3Q5, valued at $6,545.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,952.94, is a firm-fixed-price delivery order for HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. The contract is not designated as a set-aside....
This federal contract award is a delivery order (SPE2DB22D3010|SPE2DB25FP1CJ) issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The contract has a firm fixed price of $11,001.31 and an ultimate completion date of December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,265.90 firm fixed-price delivery order is for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through March 6, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX8EF
    Delivery Order

This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8EF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $45,082.30, is a Firm Fixed Price Delivery Order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/13/25, 10:13 AM